Shares of surprise tariff avoiders like pharmaceuticals and drinks firms and rate-sensitive stocks such as real estate were ...

London’s FTSE 100 was down 1.3% at 8,494.83 in afternoon trade on Thursday as investors mulled Trump’s bombshell tariff ...

TIGIT in particular has proved to be a tricky target for drug developers, and BeiGene's decision comes just a few months after MSD abandoned the development of its anti-TIGIT antibody vibostolimab ...